These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36244672)

  • 1. CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironment.
    Li F; Qi B; Yang L; Wang B; Gao L; Zhao M; Luo L
    Clin Immunol; 2022 Dec; 245():109158. PubMed ID: 36244672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHI3L1 as a Prognostic Biomarker and Therapeutic Target in Glioma.
    Zhou J; Zhao D; Tan H; Lan J; Bao Y
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming.
    Zhao T; Zeng J; Xu Y; Su Z; Chong Y; Ling T; Xu H; Shi H; Zhu M; Mo Q; Huang X; Li Y; Zhang X; Ni H; You Q
    Theranostics; 2022; 12(16):6989-7008. PubMed ID: 36276655
    [No Abstract]   [Full Text] [Related]  

  • 5. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone acetylation gene-based biomarkers as novel markers of the immune microenvironment in glioblastoma.
    Yan X; Feng L; Xu Z; Chen W; Yan H; Wu P; Ding C; Zhu X; Lu Y
    J Gene Med; 2023 Oct; 25(10):e3511. PubMed ID: 37097165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial Membrane Protein-3 and Chitinase-3-like Protein-1 as New Prognostic Predictors of Glioma, a Two-Gene Study.
    Shen K; Zhu J; Zhou S; Jin X; Zhai W; Sun L; Wu J; Yu Z
    Curr Oncol; 2023 Sep; 30(10):8686-8702. PubMed ID: 37887529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment.
    Tang F; Zhao YH; Zhang Q; Wei W; Tian SF; Li C; Yao J; Wang ZF; Li ZQ
    CNS Neurosci Ther; 2021 Aug; 27(8):951-962. PubMed ID: 33960680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
    Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma.
    Wang Y; Wong CW; Yan M; Li L; Liu T; Or PM; Tsui SK; Waye MM; Chan AM
    Cancer Lett; 2018 Aug; 429():54-65. PubMed ID: 29729901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chi3l1 Is a Modulator of Glioma Stem Cell States and a Therapeutic Target in Glioblastoma.
    Guetta-Terrier C; Karambizi D; Akosman B; Zepecki JP; Chen JS; Kamle S; Fajardo JE; Fiser A; Singh R; Toms SA; Lee CG; Elias JA; Tapinos N
    Cancer Res; 2023 Jun; 83(12):1984-1999. PubMed ID: 37101376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
    Pachocki CJ; Hol EM
    J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas.
    Guan X; Zhang C; Zhao J; Sun G; Song Q; Jia W
    EBioMedicine; 2018 Sep; 35():233-243. PubMed ID: 30131308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
    Ku BM; Lee YK; Ryu J; Jeong JY; Choi J; Eun KM; Shin HY; Kim DG; Hwang EM; Yoo JC; Park JY; Roh GS; Kim HJ; Cho GJ; Choi WS; Paek SH; Kang SS
    Int J Cancer; 2011 Mar; 128(6):1316-26. PubMed ID: 20506295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and immune cell infiltration of hypoxic phenotype-related gene signatures in glioblastoma microenvironment.
    Xiao K; Tan J; Yuan J; Peng G; Long W; Su J; Xiao Y; Xiao Q; Wu C; Qin C; Hu L; Liu K; Liu S; Zhou H; Ning Y; Ding X; Liu Q
    J Cell Mol Med; 2020 Nov; 24(22):13235-13247. PubMed ID: 33009892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy.
    Yang PS; Yu MH; Hou YC; Chang CP; Lin SC; Kuo IY; Su PC; Cheng HC; Su WC; Shan YS; Wang YC
    Theranostics; 2022; 12(1):340-361. PubMed ID: 34987649
    [No Abstract]   [Full Text] [Related]  

  • 20. Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
    Dai L; Guo X; Xing Z; Tao Y; Liang W; Shi Z; Hu W; Zhou S; Wang X
    BMC Cancer; 2023 Jan; 23(1):102. PubMed ID: 36717836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.